Carbon-neutral blockchain technology developer Core Scientific raised $54m from Celsius while autoimmune disease therapy developer Topas Therapeutics took a BIVF-backed round past $47m.

Funding Celsius, the developer of a cryptocurrency yield-earning platform, supplied $54m in funding on Tuesday for Core Scientific, a US-based company that provides what it claims is a carbon-neutral blockchain infrastructure. Core Scientific had previously received $1m in equity funding in March 2018, according to a regulatory filing. Germany-based autoimmune disease drug developer Topas Therapeutics…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.